PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Evaluating the Role of Oral Hypomethylating Agents in MDS: Considerations to Optimize Care
Visit https://www.peervoice.com/VMA860 to view the entire programme with slides. After completing “Evaluating the Role of Oral Hypomethylating Agents in MDS: Considerations to Optimize Care”, participants will be able to: Discuss the clinical implications of newer formulations of hypomethylating agents (HMAs) for patients with intermediate- to high-risk myelodysplastic syndromes (MDS) based on the evidence; Understand the importance of factoring quality-of-life considerations into treatment decisions for patients with intermediate- to high-risk MDS.